Not yet recruitingPHASE1, PHASE2NCT05441410

Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital Tuebingen
Principal Investigator
Sabine Bélard, Dr.
University Hospital Tuebingen
Intervention
Pyronaridine Tetraphosphate, Artesunate Drug Combination(drug)
Enrollment
30 enrolled
Eligibility
18-45 years · All sexes
Timeline
2025 – 2026

Collaborators

Sanaria Inc. · University of Oxford

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05441410 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials